HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yeong-Min Park Selected Research

Neoplasms (Cancer)

12/2022Improvement of STING-mediated cancer immunotherapy using immune checkpoint inhibitors as a game-changer.
1/2022Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches.
12/2021A novel form of immunotherapy using antigen peptides conjugated on PD-L1 antibody.
12/2021NIR irradiation-controlled drug release utilizing injectable hydrogels containing gold-labeled liposomes for the treatment of melanoma cancer.
4/2021Improvement of DC-based vaccines using adjuvant TLR4-binding 60S acidic ribosomal protein P2 and immune checkpoint inhibitors.
1/2021Nucleoporin 210 Serves a Key Scaffold for SMARCB1 in Liver Cancer.
12/2020Interactions between tumor-derived proteins and Toll-like receptors.
2/2020Selective Tumor-Specific Antigen Delivery to Dendritic Cells Using Mannose-Labeled Poly(d, l-lactide-co-glycolide) Nanoparticles for Cancer Immunotherapy.
1/2020Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma.
1/2020Tannic Acid Promotes TRAIL-Induced Extrinsic Apoptosis by Regulating Mitochondrial ROS in Human Embryonic Carcinoma Cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yeong-Min Park Research Topics

Disease

59Neoplasms (Cancer)
12/2022 - 12/2003
14Inflammation (Inflammations)
12/2020 - 10/2003
12Asthma (Bronchial Asthma)
03/2015 - 03/2006
8Respiratory Hypersensitivity
03/2015 - 01/2007
7Sepsis (Septicemia)
08/2019 - 03/2009
7Septic Shock (Toxic Shock Syndrome)
05/2017 - 10/2003
6Infections
12/2020 - 03/2014
6Neoplasm Metastasis (Metastasis)
01/2019 - 12/2003
4Ovarian Epithelial Carcinoma
01/2020 - 01/2016
4Endotoxemia
08/2019 - 07/2011
4Breast Neoplasms (Breast Cancer)
06/2018 - 09/2011
3Melanoma (Melanoma, Malignant)
12/2021 - 05/2017
3Carcinoma (Carcinomatosis)
01/2020 - 05/2006
3Thymoma (Thymic Carcinoma)
05/2015 - 02/2013
3Paratuberculosis (Johne's Disease)
02/2014 - 07/2009
3Chronic Disease (Chronic Diseases)
12/2008 - 06/2005
2Alzheimer Disease (Alzheimer's Disease)
12/2021 - 06/2006
2Liver Neoplasms (Liver Cancer)
01/2021 - 01/2006
2Immune System Diseases (Immune Disorders)
07/2018 - 10/2013
2Shock
01/2017 - 08/2009
2Experimental Arthritis
03/2016 - 06/2003
2Prostatic Neoplasms (Prostate Cancer)
05/2013 - 09/2011
1Bites and Stings (Sting)
12/2022

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
12/2021 - 06/2007
14CytokinesIBA
12/2022 - 10/2003
14VaccinesIBA
12/2022 - 01/2007
13AntigensIBA
12/2021 - 01/2007
12OvalbuminIBA
01/2016 - 01/2007
9LipopolysaccharidesIBA
12/2021 - 10/2003
7Pharmaceutical PreparationsIBA
08/2019 - 05/2006
6Peptides (Polypeptides)IBA
12/2022 - 09/2015
6Interleukin-10 (Interleukin 10)IBA
01/2018 - 03/2009
6CurcuminIBA
01/2013 - 06/2005
5Small Interfering RNA (siRNA)IBA
01/2022 - 02/2006
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2021 - 10/2003
5Toll-Like Receptor 4IBA
04/2021 - 07/2011
5Neoplasm Antigens (Tumor Antigens)IBA
04/2021 - 12/2005
5Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
05/2015 - 03/2007
4Immune Checkpoint InhibitorsIBA
12/2022 - 01/2020
4InterferonsIBA
12/2022 - 05/2015
4Liposomes (Liposome)IBA
12/2021 - 10/2013
4LigandsIBA
12/2020 - 05/2007
4Interleukin-12 (IL 12)IBA
04/2016 - 10/2003
4Glycogen Synthase (Synthase I)IBA
01/2016 - 07/2011
4Phenobarbital (Luminal)FDA Link
03/2015 - 01/2007
4Methacholine Chloride (Methacholine)FDA Link
05/2012 - 09/2008
4Proteoglycans (Proteoglycan)IBA
09/2005 - 06/2003
3B7-H1 AntigenIBA
12/2022 - 12/2021
3Cancer VaccinesIBA
04/2021 - 05/2012
3Polylactic Acid-Polyglycolic Acid CopolymerIBA
02/2020 - 01/2016
3Phosphotransferases (Kinase)IBA
08/2019 - 07/2011
3Paclitaxel (Taxol)FDA LinkGeneric
11/2018 - 01/2016
3ResveratrolIBA
05/2015 - 06/2006
3Immunologic Adjuvants (Immunologic Adjuvant)IBA
08/2014 - 05/2012
3AllergensIBA
05/2012 - 04/2011
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2008 - 05/2006
3Polysaccharides (Glycans)IBA
11/2004 - 10/2003
2Interferon-gamma (Interferon, gamma)IBA
12/2022 - 02/2006
2Cisplatin (Platino)FDA LinkGeneric
12/2022 - 12/2021
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 01/2020
2Pattern Recognition ReceptorsIBA
12/2020 - 03/2014
2Toll-Like Receptors (Toll-Like Receptor)IBA
12/2020 - 01/2016
2Annexin A5IBA
01/2020 - 09/2016
2linaloolIBA
01/2020 - 01/2016
2PolyphenolsIBA
01/2020 - 05/2006
2Therapeutic UsesIBA
08/2019 - 03/2011
2Hyaluronic Acid (Hyaluronan)IBA
11/2018 - 11/2018
2Focal Adhesion Protein-Tyrosine KinasesIBA
11/2018 - 04/2017
2ChitosanIBA
11/2018 - 12/2016
2Messenger RNA (mRNA)IBA
11/2018 - 06/2007
2nobiletinIBA
06/2018 - 04/2017
2Vaccine AdjuvantsIBA
01/2018 - 09/2015
2QuercetinIBA
01/2018 - 03/2009
2EndotoxinsIBA
01/2018 - 05/2017
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2017 - 01/2012
2Platelet Activating FactorIBA
01/2017 - 08/2009
2Interleukin-6 (Interleukin 6)IBA
04/2016 - 12/2006
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2016 - 03/2014
2Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2015 - 08/2014
2Biological ProductsIBA
05/2013 - 07/2006
2Reactive Oxygen Species (Oxygen Radicals)IBA
05/2013 - 09/2011
2Fibronectins (Fibronectin)IBA
05/2012 - 07/2009
2sulforaphaneIBA
05/2012 - 05/2007
2InterleukinsIBA
04/2012 - 02/2012
2Glycogen Synthase Kinase 3IBA
04/2012 - 07/2011
2EnzymesIBA
02/2009 - 03/2007
2Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2008 - 12/2006
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2008 - 06/2006
2pinitolIBA
06/2007 - 01/2007
2CaspasesIBA
01/2006 - 06/2005
1vadimezanIBA
12/2022
1Interferon Type IIBA
12/2022
1HydrogelsIBA
12/2021
1GoldIBA
12/2021

Therapy/Procedure

18Immunotherapy
12/2022 - 12/2005
14Therapeutics
12/2022 - 03/2006
9Drug Therapy (Chemotherapy)
12/2022 - 01/2007
1Radiotherapy
12/2022
1Injections
12/2021
1Operative Surgical Procedures
12/2021